Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections.

Fatourechi MM, Kudva YC, Murad MH, Elamin MB, Tabini CC, Montori VM.

J Clin Endocrinol Metab. 2009 Mar;94(3):729-40. doi: 10.1210/jc.2008-1415. Review.

PMID:
19088167
2.
3.
4.

Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.

Jeitler K, Horvath K, Berghold A, Gratzer TW, Neeser K, Pieber TR, Siebenhofer A.

Diabetologia. 2008 Jun;51(6):941-51. doi: 10.1007/s00125-008-0974-3. Review.

PMID:
18351320
5.

Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.

Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH.

Ann Intern Med. 2012 Sep 4;157(5):336-47. Review.

PMID:
22777524
6.
7.
8.
9.

A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.

Herman WH, Ilag LL, Johnson SL, Martin CL, Sinding J, Al Harthi A, Plunkett CD, LaPorte FB, Burke R, Brown MB, Halter JB, Raskin P.

Diabetes Care. 2005 Jul;28(7):1568-73.

PMID:
15983302
10.

Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review.

Roze S, Smith-Palmer J, Valentine W, de Portu S, Nørgaard K, Pickup JC.

Diabet Med. 2015 Nov;32(11):1415-24. doi: 10.1111/dme.12792. Review.

PMID:
25962621
11.
12.

Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study.

Ruiz-de-Adana MS, Dominguez-Lopez ME, Gonzalez-Molero I, Machado A, Martin V, Cardona I, de-la-Higuera M, Tapia MJ, Soriguer F, Anarte MT, Rojo-Martínez G.

Med Clin (Barc). 2016 Mar 18;146(6):239-46. doi: 10.1016/j.medcli.2015.09.020.

PMID:
26656958
13.

Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS).

Little SA, Leelarathna L, Walkinshaw E, Tan HK, Chapple O, Lubina-Solomon A, Chadwick TJ, Barendse S, Stocken DD, Brennand C, Marshall SM, Wood R, Speight J, Kerr D, Flanagan D, Heller SR, Evans ML, Shaw JA.

Diabetes Care. 2014 Aug;37(8):2114-22. doi: 10.2337/dc14-0030.

PMID:
24854041
14.
15.

OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methods.

Aronson R, Cohen O, Conget I, Runzis S, Castaneda J, de Portu S, Lee S, Reznik Y; OpT2mise Study Group..

Diabetes Technol Ther. 2014 Jul;16(7):414-20. doi: 10.1089/dia.2013.0363.

PMID:
24735134
16.

Does treatment with an insulin pump improve glycaemic control in children and adolescents with type 1 diabetes? A retrospective case-control study.

Brorsson AL, Viklund G, Örtqvist E, Lindholm Olinder A.

Pediatr Diabetes. 2015 Nov;16(7):546-53. doi: 10.1111/pedi.12209.

PMID:
25327782
17.

Fear of hypoglycemia in type 1 diabetes managed by continuous subcutaneous insulin infusion: is it associated with poor glycemic control?

Nixon R, Pickup JC.

Diabetes Technol Ther. 2011 Feb;13(2):93-8. doi: 10.1089/dia.2010.0192.

PMID:
21284474
18.

Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes.

Cohen ND, Hong ES, Van Drie C, Balkau B, Shaw J.

Diabetes Technol Ther. 2013 Jul;15(7):544-9. doi: 10.1089/dia.2012.0331.

PMID:
23617252
19.

Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.

Colquitt JL, Green C, Sidhu MK, Hartwell D, Waugh N.

Health Technol Assess. 2004 Oct;8(43):iii, 1-171. Review.

Supplemental Content

Support Center